Literature DB >> 17120167

Anti-microbial photodynamic therapy: useful in the future?

Tim Maisch1.   

Abstract

Previous chapters in this volume have focused on fundamental principles and clinical applications of PDT. This chapter will attempt to outline emerging areas of research to identify some new applications that may become useful in the future in clinical practise. The worldwide rise in antibiotic resistance has driven research to the development of novel anti-microbial strategies. Cutaneous diseases caused by MRSA are ideally suited to treatment by anti-microbial photodynamic therapy for eradicating localized infections and for modulating wound healing due to the ability to deliver photosensitizer and light with topical application. The use of photosensitizer and light as an anti-microbial agent against periodontal microbial biofilms should also represent an attractive method of eliminating oral bacteria. Suitable light sources, laser light and non-coherent light will be briefly covered. This chapter will focus on some aspects of anti-microbial photodynamic therapy that appear to be promising for dermatological indications and inactivation of pathogenic bacteria within the oral cavity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120167     DOI: 10.1007/s10103-006-0409-7

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   2.555


  91 in total

1.  Photodynamic therapy for nevus sebaceus with topical delta-aminolevulinic acid.

Authors:  C C Dierickx; M Goldenhersh; P Dwyer; A Stratigos; M Mihm; R R Anderson
Journal:  Arch Dermatol       Date:  1999-06

2.  Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy.

Authors:  D J Robinson; P Collins; M R Stringer; D I Vernon; G I Stables; S B Brown; R A Sheehan-Dare
Journal:  Acta Derm Venereol       Date:  1999-11       Impact factor: 4.437

Review 3.  Antibiotics in periodontal therapy: advantages and disadvantages.

Authors:  J Slots; T E Rams
Journal:  J Clin Periodontol       Date:  1990-08       Impact factor: 8.728

Review 4.  Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

Authors:  S K Fridkin
Journal:  Clin Infect Dis       Date:  2000-12-13       Impact factor: 9.079

5.  Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine.

Authors:  Anna Segalla; Claudio D Borsarelli; Silvia E Braslavsky; John D Spikes; Gabrio Roncucci; Donata Dei; Giacomo Chiti; Giulio Jori; Elena Reddi
Journal:  Photochem Photobiol Sci       Date:  2002-09       Impact factor: 3.982

6.  Photodynamic action of methylene blue: repair and mutation in Escherichia coli.

Authors:  S Menezes; M A Capella; L R Caldas
Journal:  J Photochem Photobiol B       Date:  1990-05       Impact factor: 6.252

7.  The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.

Authors:  R S Stern; N Laird
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

8.  Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.

Authors:  R S Stern; L A Thibodeau; R A Kleinerman; J A Parrish; T B Fitzpatrick
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

9.  In vitro effect of 5-aminolaevulinic acid plus visible light on Candida albicans.

Authors:  Giuseppe Monfrecola; Enrico Maria Procaccini; Maurizio Bevilacqua; Alfredo Manco; Gabriella Calabro; Pietro Santoianni
Journal:  Photochem Photobiol Sci       Date:  2004-01-28       Impact factor: 3.982

Review 10.  Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.

Authors:  C Fritsch; P Lehmann; W Stahl; K W Schulte; E Blohm; K Lang; H Sies; T Ruzicka
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  60 in total

1.  Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection.

Authors:  Moshe Giladi; Yaara Porat; Alexandra Blatt; Esther Shmueli; Yoram Wasserman; Eilon D Kirson; Yoram Palti
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 2.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

3.  Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).

Authors:  J C Junqueira; A O C Jorge; J O Barbosa; R D Rossoni; S F G Vilela; A C B P Costa; F L Primo; J M Gonçalves; A C Tedesco; J M A H Suleiman
Journal:  Lasers Med Sci       Date:  2012-01-26       Impact factor: 3.161

4.  Microbial growth inhibition by alternating electric fields.

Authors:  Moshe Giladi; Yaara Porat; Alexandra Blatt; Yoram Wasserman; Eilon D Kirson; Erez Dekel; Yoram Palti
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

5.  Effect of photodynamic therapy on the healing of cutaneous third-degree-burn: histological study in rats.

Authors:  Valdir Gouveia Garcia; Marcos Alcântara de Lima; Tetuo Okamoto; Luís Alberto Milanezi; Erivan Clementino Gualberto Júnior; Leandro Araújo Fernandes; Juliano Milanezi de Almeida; Letícia Helena Theodoro
Journal:  Lasers Med Sci       Date:  2009-06-17       Impact factor: 3.161

6.  Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability.

Authors:  Isabela Bueno Rosseti; Luciene Reginato Chagas; Maricilia Silva Costa
Journal:  Lasers Med Sci       Date:  2013-11-01       Impact factor: 3.161

7.  Clinical and microbiological effects of photodynamic therapy associated with nonsurgical periodontal treatment. A 6-month follow-up.

Authors:  Leticia Helena Theodoro; Simoni Paro Silva; Juliana Rico Pires; Glaucia Helena Garcia Soares; Ana Emilia Farias Pontes; Elizangela Partata Zuza; Denise Madalena P Spolidório; Benedicto Egbert Correa de Toledo; Valdir Gouveia Garcia
Journal:  Lasers Med Sci       Date:  2011-06-18       Impact factor: 3.161

8.  Inactivation of Aggregatibacter actinomycetemcomitans by two different modalities of photodynamic therapy using Toluidine blue O or Radachlorin as photosensitizers: an in vitro study.

Authors:  Neda Moslemi; Pardis Soleiman-Zadeh Azar; Abbas Bahador; Nina Rouzmeh; Nasim Chiniforush; Mojgan Paknejad; Reza Fekrazad
Journal:  Lasers Med Sci       Date:  2014-07-01       Impact factor: 3.161

Review 9.  Can light-based approaches overcome antimicrobial resistance?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Drug Dev Res       Date:  2018-08-02       Impact factor: 4.360

Review 10.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.